Articles tagged with Covid 19 Vaccines
A new study aims to investigate whether vaccination against SARS-CoV-2 can protect children at increased genetic risk of developing type 1 diabetes. The AVAnT1A Study, the largest intervention study to date, examines the relationship between viral infections and early childhood development.
Researchers at the University of California, Berkeley, have successfully produced the QS-21 adjuvant in yeast, which is currently extracted from tree bark. The production process is cheaper and more environmentally friendly than traditional methods, making it a promising solution for lowering vaccine costs and increasing availability.
A study published in PLOS ONE found that people in Europe primarily consume trustworthy news, but a small percentage rely on questionable sources. The ratio of questionable news to reliable news consumption differs between countries, highlighting the need for context-specific approaches to fighting misinformation.
A third Covid vaccine dose has been shown to improve defensive antibody responses in some clinically extremely vulnerable patients. The trial found that 90% of patients who received a booster dose developed significant antibodies, but more than half of those with low initial responses saw no improvement.
A new research project showed that mobile vaccination teams are an effective way to increase vaccination uptake in remote areas of Sierra Leone. Immunization rates increased by up to 26% in trial villages, and the cost was about $33 per person, making it a cost-effective intervention.
Researchers developed a new 'proactive vaccinology' approach to build vaccines before disease-causing pathogens emerge. The Quartet Nanocage vaccine trains the immune system to target specific regions of eight coronaviruses, providing broad protection against known and unknown strains.
Researchers developed a simple and efficient method for diversifying reactive end-groups on poly(2-oxazoline)s, enabling rapid exploration of poly(2-oxazoline)-based nanomedicine platforms. The approach was shown to produce POx-based lipid nanoparticles comparable in transfection capability to their PEGylated counterparts.
A team of scientists has developed a novel vaccine approach that induces long-lasting protective immunity against SARS-CoV-2 virus in pre-clinical models. The Clec9A-RBD antibody construct targets specific dendritic cells, leading to exceptional durability of immune responses and potential to address shortcoming of current mRNA vaccines.
Researchers found that T cells and memory B cells provide durable protection against symptomatic SARS-CoV-2 infection, with levels attainable after two doses of mRNA vaccination. The study suggests a two-dose vaccination regimen for children against COVID-19.
A survey across 23 countries found that the global population's overall trust in vaccination did not diminish despite COVID-19 pandemic challenges. More than 60% of participants reported increased willingness to get vaccinated for diseases other than COVID-19, suggesting a general openness to vaccination. The study emphasizes the impor...
A new survey of 23,000 respondents from 23 countries reports mixed signals on the current acceptance of vaccines generally, especially COVID-19 boosters. The study found that global uptake of at least one COVID-19 vaccine dose rose to 87.8%, but intent to get a booster was lower compared to previous years.
New research reveals updated vaccines provide a strong immune response against previous strains and emerging variants of COVID-19. Regular vaccinations are recommended for older people or those with underlying medical conditions to combat the virus.
A study found a significant increase in negative tweets about vaccines after COVID-19 jabs became available, coinciding with government and healthcare announcements. The researchers argue that a new approach is needed to address negative messaging, avoiding terms like 'anti-vaxxers'.
A Brazilian study found that a major bivalent COVID-19 vaccine induces neutralizing antibodies against the original coronavirus strain and subvariants of omicron. The vaccine's effectiveness was confirmed, but its importance in controlling disease was limited by its focus on the original strain.
A cohort study found statistical signals for myocarditis and pericarditis after BNT162b2 vaccination in children aged 12-17 years, consistent with previous reports. Seizures after mRNA-1273 vaccinations in younger age groups require a robust epidemiologic investigation to confirm findings.
A new study published in JAMA found X's Community Notes resulted in hundreds-of-millions of views of accurate and credible COVID-19 vaccine education, suggesting considerable potential for correcting misinformation. The notes typically addressed obvious misinformation, offering corrections from credible sources.
A new UK/German study suggests that perceptions of serious side effects are less than half as important as common side effects, such as fatigue or pain at the injection site, when making a decision to be vaccinated. The study found that educating the public about vaccine safety and efficacy is crucial in boosting vaccination uptake.
A large-scale study of 3.9 million children found that COVID-19 vaccination significantly reduced the incidence of SARS-CoV-2 infection and hospitalization among kids in California. The study suggests that vaccination is an effective strategy to prevent severe COVID-19 cases in pediatric populations.
Researchers investigate link between HPV vaccination and autoimmune disorder anti-NMDA receptor encephalitis. Cases associated with HPV vaccination have been reported, but underlying mechanism unclear. The study uses phylogenetic analysis of microRNA biomarkers to explore this association.
Researchers at UC Riverside demonstrate a new vaccine strategy targeting a common viral genome part, eliminating the need for annual booster shots. The vaccine uses small RNA molecules to boost the immune system, making it safe for babies and those with weakened immunity.
Researchers analyzed data on 9060 family physicians to find a correlation between those with the largest share of unvaccinated patients, typically serving marginalized communities, who had less support in their practices. These physicians were more likely to be male, older, and work in fee-for-service models than the remaining 90%.
A new study found that younger people from high-income areas accessed vaccines ahead of schedule, particularly in New York City. This led to lower coverage rates in low-income areas with high proportions of older residents, resulting in higher mortality rates over the year.
Researchers found RSV was less common but similar in severity to COVID-19 and influenza among unvaccinated patients. Among vaccinated patients, RSV disease was more severe than both COVID-19 and influenza for serious outcomes.
A large multi-state study found COVID-19 vaccines are as effective for adults with anxiety or depression as for those without these conditions. Unvaccinated individuals with mental illness had a higher rate of hospitalization for COVID-19 than those without a psychiatric diagnosis.
A groundbreaking study demonstrates that intradermal administration of naked mRNA induces robust vaccination against SARS CoV-2 in mice and primates. The novel approach avoids the use of lipid nanoparticles, which can cause adverse reactions, allowing for multiple doses over a lifetime.
Georgia Tech researchers have developed a trivalent vaccine that offers broad protection against not only SARS-CoV-2 variants but also other bat sarbecoviruses. The groundbreaking vaccine has shown complete protection with no trace of virus in the lungs, marking a significant step toward a universal vaccine for coronaviruses.
A recent study found a significant association between COVID-19 vaccine adverse events and political party affiliation. The more Republican states were, the higher the reported adverse events among vaccine recipients and clinicians.
Researchers found a 32% vaccine uptake among patients asked about receiving the flu shot and a 41% uptake for those who received a pamphlet, watched a video, and were told about benefits. The study suggests a systematic approach to increase vaccine uptake among underserved populations.
A study found that an annual vaccination campaign with a second dose for children under 2 years old and individuals aged 50 and over can significantly reduce hospitalizations, deaths, and healthcare spending. The optimal timing for the second vaccination is delivering it 5 months after initial vaccination.
The COVID-19 pandemic significantly interrupted pediatric healthcare, resulting in foregone care, well-child visits, and vaccinations for vulnerable populations. Non-Hispanic White children were less likely to experience these gaps, while virtual school formats increased the risk of foregone care.
A new study found that COVID-19 vaccine uptake was low across all four UK nations, with only 35% of children receiving the first dose. The study also revealed disparities in vaccination rates based on age, sex, household factors, and location.
Researchers found that early antibiotic treatment accelerated recovery in COVID-19 patients. The study used a combination of antibiotics, including amoxicillin and rifaximin, within the first three days of infection. This treatment significantly reduced the risk of long-term COVID symptoms.
A new AI system can predict people's attitudes towards vaccines using a small set of demographic and judgment variables. The study, which analyzed 3,476 adults in the US, found that the predictive model was accurate with moderate to high precision.
A study of over 11,000 Medicare beneficiaries aged 65+ who experienced stroke after COVID-19 bivalent vaccination found no evidence of a significantly elevated stroke risk during the days immediately following vaccination. The researchers concluded that the vaccine's safety profile is supported by this analysis.
A new multitasking substance has been identified to prevent and treat both flu and COVID-19 infections concurrently. The long-acting recombinant cytokine protein rhIL-7-hyFc demonstrated therapeutic and preventive effects against various respiratory diseases, including COVID-19, influenza virus, and respiratory syncytial virus.
Researchers found that adding a note to play up psychological sense of ownership was more effective at convincing people to get the booster. This approach outperformed lab findings and expert insights, highlighting the importance of reproducibility in behavioral science.
Researchers found that initial vaccinations against the ancestral SARS-CoV-2 strain shape immune responses to newer variants BA.5 and XBB, with higher B cell repertoire leading to more effective cross-reactive immunity. This 'immunological imprinting' effect could impact future vaccine designs.
Research suggests that long COVID's impact on the health system is due to high volumes of COVID-19 cases rather than symptom severity. Symptoms reported with long COVID include fatigue, brain fog, and shortness of breath, but are indistinguishable from those experienced by individuals with seasonal influenza or other post-viral illnesses.
Researchers developed a protein-based vaccine candidate called SpyCage that induces an immune response in rodent models, clearing COVID-19 infections more quickly than controls. The platform has the potential to prevent infection and transmission of respiratory viruses like SARS-CoV-2 by inducing a mucosal immune response.
A recent study found that newer monovalent COVID vaccines generated higher levels of antibodies against a range of Omicron variants, including the XBB and BQ.1.1 strains. The researchers also discovered that these vaccines increased mucosal antibody production, but not neutralizing antibody levels in the nasal cavity.
Researchers found that T cells can reshape their memory and maintain diversity against COVID-19 variants in response to successive mRNA vaccinations. The study revealed a shift among clonotypes, with a change from early responders to main responders after the second shot, suggesting a new dominant population of effector-memory T cells.
A landmark study published in JAMA Pediatrics found that COVID vaccines are safe to administer during pregnancy, with no abnormal delays in infants when tested at 12 months and 18 months. The study of over 2,200 infants from across the country also found an increased risk of delay among male infants at 12 months but not at 18 months.
A simulation model predicts that frequent booster vaccination is highest effective for those over 65 years old and the immunocompromised to prevent severe disease. The model suggests that annual or twice-yearly boosters reduce severe infections in these high-risk populations by half.
Researchers at MIT have developed a new type of nanoparticle that can both deliver vaccines and act as an adjuvant to generate a strong immune response. The particles, called metal-organic frameworks (MOFs), were shown to be effective in delivering the SARS-CoV-2 spike protein and boosting the immune system's response.
A recent study published in Lancet Infectious Diseases found that vaccinated individuals had a lower risk of severe COVID-19 outcomes compared to unvaccinated individuals. The study also showed significant reductions in hospitalization and death rates from COVID-19, particularly among older individuals and those with compromised immune...
Researchers at FAU investigated a man who received over 200 Covid-19 vaccinations, finding that his immune system remained fully functional and even showed higher concentrations of antibodies against SARS-CoV-2. No negative effects were observed on the immune response against other pathogens.
A large binational study found that SARS-CoV-2 infection was associated with an increased risk of autoimmune inflammatory rheumatic diseases (AIRDs) extending up to 12 months after infection. Vaccination showed some protection against AIRDs, particularly among those who were vaccinated.
A recent study found that the latest COVID-19 booster shot significantly reduces adults' risk of moderate or severe disease. The study analyzed data from September 2023 to January 2024 and showed that the updated vaccine provided protection against emergency department visits and hospitalizations, with a reduction of over half.
Researchers at Oregon Health & Science University found that COVID-19 vaccination during the first half of the menstrual cycle can cause slight, temporary changes in cycle length. This effect typically resolves after vaccination.
A recent MSU-co-authored study identifies 10 insights to reduce vaccine hesitancy on social media, emphasizing the importance of messaging tailored to specific groups, correcting misinformation, and leveraging trust in vaccination campaigns. The research aims to alleviate bias and improve vaccine uptake behaviors.
A long-term analysis of over 8,000 samples revealed that SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting. Booster vaccination equalized differences in antibody concentration between participants with and without pre-existing immunity.
Researchers propose renaming VAERS as the Vaccine Safety Sentinel to reduce misinformation, citing a lack of public understanding of the system's unverified reports. They also recommend improving the system with raw data and expanded public education.
Researchers developed a new recombinant flu vaccine called Hexaplex, which provided superior protection against H1N1 and H3N2 viruses in animal models. The vaccine's combination of six proteins from different groups resulted in strong antibody production and T-cell activation, offering broader immunity.
A recent study published in JAMA Network Open found that vaccinated adults with hematologic cancers were at high risk of severe COVID-19, even after receiving treatment. The study included 6,122 patients and showed no significant decline in severe cases through mid-2022.
A recent study published in the American Journal of Obstetrics and Gynecology found that COVID-19 vaccination during pregnancy significantly reduces the risk of neonatal infections and premature birth. Vaccinated mothers' babies had lower rates of respiratory distress syndrome and days spent in the NICU compared to unvaccinated mothers.
A new study aims to enhance and prolong vaccine effectiveness by delivering adjuvants to white blood cells using lipid nanoparticles. The research, led by WVU professor Sharan Bobbala, has the potential to provide broader protection against evolving viruses and multiple diseases.
The study found that HPV vaccination coverage did not increase during the COVID-19 pandemic, indicating pandemic-related disruptions in initiating the vaccine. This suggests that efforts to promote HPV vaccination among young adults may need to be continued and strengthened.
A global vaccine safety study involving 99 million people found potential risks of myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis after mRNA and viral vector COVID-19 vaccinations. The study's findings were made possible by the Global Vaccine Data Network.
A clinical study published in Microbiology Spectrum found that COVID-19 vaccines still provide a robust immune response in immunocompromised individuals, including cancer patients undergoing treatment. This finding is crucial for clinicians and patients, as it suggests vaccination can help prevent infection and disease progression.
Research from the National Institute of Allergy and Infectious Diseases found that COVID-19 vaccination during pregnancy can provide protection to infants for at least six months. Infants born to mothers who received both doses of a COVID-19 vaccine had higher antibody levels and greater protection from infection.